Caxton Associates LP Organogenesis Holdings Inc. Transaction History

Caxton Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.61 - $4.49 $81,103 - $139,522	31,074 New	31,074 $88,000
Q1 2023 May 15, 2023	BUY	$1.89 - $2.93 $23,258 - $36,056	12,306 New	12,306 $26,000
Q2 2021 Aug 16, 2021	SELL	$14.92 - $23.23 $583,789 - $908,943	-39,128 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.33 - $21.06 $286,808 - $824,035	39,128 New	39,128 $713,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $505M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.